Nabil Mouadden
Co-founder and CEO
AI researcher in medical imaging, finishing a PhD at CentraleSupélec, Université Paris-Saclay, on predicting how lung disease evolves from a patient's earlier CT scans. First author at MICCAI 2025 and MIDL 2025. Before that, three years building payment software certified by Visa and Mastercard.